Clinical Research Directory
Browse clinical research sites, groups, and studies.
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial studies the side effects and best way to perform yttrium Y-90 radioembolization in treating patients with liver cancer that has spread to other places in the body (metastatic). Yttrium Y-90 radioembolization is a therapy that injects radioactive microspheres directly into an artery that feeds liver tumors to cut off their blood supply. Performing yttrium Y-90 radioembolization in a single session may make treatment faster, minimize patient travel, and decrease the overall cost of the procedure.
Official title: Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2017-01-09
Completion Date
2027-01-31
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
Angiography
Undergo angiography
Computed Tomography
Undergo SPECT-CT
Planar Imaging
Undergo planar imaging
Radioembolization
Undergo radioembolization
Single Photon Emission Computed Tomography
Undergo SPECT-CT
Technetium Tc-99m Albumin Aggregated
Given via arterial catheter
Yttrium Y 90 Resin Microspheres
Given via arterial catheter
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States